Lindsay A. Renfro

Also affiliated with University of Southern California, California Southern University, Children's Oncology Group

MedicineBiochemistry, Genetics and Molecular BiologyMathematics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile

0.661Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Rhabdoid Tumor of the Kidney and Soft Tissues: Results from National Wilms Tumor Study‐5 and Children's Oncology Group Study AREN0321

Pediatric Blood & Cancer(2024)10.1002/pbc.31490

Top 44%

0.420DataRank

Top 44%9 citations

Lindsay A. Renfro, Paul E. Grundy, Elizabeth J. Perlman, John A. Kalapurakal, Peter F. Ehrlich +15 more

Papers

Driven by 30 papers — median percentile 47. Top paper: “Genetic and epigenetic features of bilateral Wilms tumor predisposition in patients from the Children’s Oncology Group AREN18B5-Q”.

Genetic and epigenetic features of bilateral Wilms tumor predisposition in patients from the Children’s Oncology Group AREN18B5-Q

Nature Communications(2023)10.1038/s41467-023-43730-0

N/A

0.778DataRank · unranked

31 citations

Changde Cheng, Justin Williams, Timothy I. Shaw, Emília M. Pinto, Karissa M. Dieseldorff Jones +29 more

Treatment of children with favorable histology Wilms tumor with extrapulmonary metastases: A report from the COG studies AREN0533 and AREN03B2 and NWTSG study NWTS‐5

Cancer(2023)10.1002/cncr.35099

N/A

0.567DataRank · unranked

21 citations

Carly R. Varela, Lindsay A. Renfro, Brett Tornwall, David Dix, Peter F. Ehrlich +13 more

Rhabdoid Tumor of the Kidney and Soft Tissues: Results from National Wilms Tumor Study‐5 and Children's Oncology Group Study AREN0321

Pediatric Blood & Cancer(2024)10.1002/pbc.31490

Top 44%

0.420DataRank

Top 44%9 citations

Lindsay A. Renfro, Paul E. Grundy, Elizabeth J. Perlman, John A. Kalapurakal, Peter F. Ehrlich +15 more

Treatment and outcomes of clear cell sarcoma of the kidney: A report from the Children's Oncology Group studies AREN0321 and AREN03B2

Cancer(2024)10.1002/cncr.35266

N/A

0.402DataRank · unranked

12 citations

Lindsay A. Renfro, Ian Tfirn, Najat C. Daw, John A. Kalapurakal, Peter F. Ehrlich +12 more

Race and Ethnic Group Enrollment and Outcomes for Wilms Tumor: Analysis of the Current Era Children’s Oncology Group Study, AREN03B2

Journal of the American College of Surgeons(2024)10.1097/xcs.0000000000000999

Top 61%

0.241DataRank

Top 61%4 citations

Lindsay A. Renfro, Daniel J. Benedetti, Meera Kotagal, Hannah M. Phelps, Peter F. Ehrlich +13 more

Tumor-specific immune responses and biomarkers in pediatric patients with high-risk Hodgkin lymphoma

Blood Advances(2025)10.1182/bloodadvances.2025016797

N/A

0.208DataRank · unranked

3 citations

Lindsay A. Renfro, Hema Dave, G. Pezzella, Qinglin Pei, Lisa Giulino‐Roth +6 more

BRAF Exon 15 Mutations in the Evaluation of Well-Differentiated Epithelial Nephroblastic Neoplasms in Children: A Report From the Children’s Oncology Group Study AREN03B2

Archives of Pathology & Laboratory Medicine(2023)10.5858/arpa.2022-0528-oa

N/A

0DataRank · unranked

2 citations

Lindsay A. Renfro, Lawrence J. Jennings, Elizabeth A. Mullen, James I. Geller, Kelly Vallance +3 more

The Genetic and Epigenetic Features of Bilateral Wilms Tumor Predisposition: A Report from the Children's Oncology Group AREN18B5-Q Study

Research Square(2023)10.21203/rs.3.rs-2675436/v1

N/A

0DataRank · unranked

2 citations

Changde Cheng, Justin Williams, Timothy I. Shaw, Emília M. Pinto, Karissa Dieseldorff-Jones +29 more

Long‐term outcomes and patterns of relapse in patients with bilateral Wilms tumor or bilaterally predisposed unilateral Wilms tumor, a report from the COG AREN0534 study

International Journal of Cancer(2024)10.1002/ijc.35080

N/A

0DataRank · unranked

10 citations

Jack Brzezinski, Lindsay A. Renfro, Brett Tornwall, Marcus M. Malek, Daniel J. Benedetti +15 more

Bilateral Wilms tumor with anaplasia: A report from the Children's Oncology Group Study AREN0534

Pediatric Blood & Cancer(2024)10.1002/pbc.30981

N/A

0DataRank · unranked

7 citations

Jennifer H. Aldrink, Lindsay A. Renfro, Elizabeth A. Mullen, Andrew J. Murphy, Jack Brzezinski +16 more

Protocol-Stipulated Dose Modification to Manage Chemotherapy-Induced Peripheral Neuropathy in Children, Adolescents, and Young Adults With High-Risk Hodgkin Lymphoma

JCO Oncology Practice(2024)10.1200/op.24.00089

N/A

0DataRank · unranked

7 citations

Susan K. Parsons, Frank G. Keller, Lindsay A. Renfro, Qinglin Pei, Angie Mae Rodday +7 more

Global Statistics and Data Sciences (GSDS), BeiGene USA, Fulton, MD

Medical Research Archives(2024)10.18103/mra.v12i1.5088

N/A

0DataRank · unranked

0 citations

Haitao Pan, Gregory H. Reaman, Satrajit Roychoudhury, Chengxing Lu, Lindsay A. Renfro +5 more

Global Statistics and Data Sciences (GSDS), BeiGene USA, Fulton, MD

Medical Research Archives(2024)10.18103/mra.v11i11.5088

N/A

0DataRank · unranked

0 citations

Haitao Pan, Gregory H. Reaman, Satrajit Roychoudhury, Chengxing Lu, Lindsay A. Renfro +5 more

Updated favourable-histology Wilms tumour risk stratification: rationale for future Children’s Oncology Group clinical trials

Nature Reviews Urology(2025)10.1038/s41585-025-01055-1

N/A

0DataRank · unranked

13 citations

Nicholas G. Cost, Peter F. Ehrlich, Nicholas F. Evageliou, Elizabeth Fialkowski, Lauren Parsons +13 more

Treatment of focal anaplastic Wilms tumor: A report from the Children's Oncology Group AREN0321 and AREN03B2 studies

Cancer(2025)10.1002/cncr.35713

N/A

0DataRank · unranked

7 citations

Najat C. Daw, Lindsay A. Renfro, James I. Geller, John A. Kalapurakal, Geetika Khanna +10 more

Comparison of Contemporary Radiation Therapy Approaches in Combined Modality Treatment on Pediatric High-Risk Classic Hodgkin Lymphoma Study: AHOD 1331

International Journal of Radiation Oncology*Biology*Physics(2025)10.1016/j.ijrobp.2025.06.3876

N/A

0DataRank · unranked

6 citations

Raymond B. Mailhot Vega, Lindsay A. Renfro, Qinglin Pei, Anne-Marie Charpentier, Rahul R. Parikh +15 more

Incorporation of patient-reported outcomes in pediatric cancer clinical trials: design, implementation, and dissemination

JNCI Journal of the National Cancer Institute(2025)10.1093/jnci/djaf083

N/A

0DataRank · unranked

4 citations

Kathleen Montgomery, Adam DuVall, Michael Roth, Mark Krailo, Michelle M. Nuño +13 more

PET Response and Outcome in Low‐Risk Nodular Lymphocyte‐Predominant Hodgkin Lymphoma: Children's Oncology Group Study AHOD03P1

Pediatric Blood & Cancer(2025)10.1002/pbc.31606

N/A

0DataRank · unranked

3 citations

Yue Wu, Kathleen M. McCarten, Lindsay A. Renfro, Qinglin Pei, Kara M. Kelly +4 more

Associations of Patient Age, Tumor Nephrectomy Weight, and Tumor Diameter with Event-Free and Overall Survival in Stage I or II Favorable Histology Wilms Tumor

Annals of Surgery(2025)10.1097/sla.0000000000006726

N/A

0DataRank · unranked

3 citations

Kelly Vallance, Ian Tfirn, Nicholas F. Evageliou, Daniel J. Benedetti, Robert C. Shamberger +15 more

Evaluation of the Childhood Hodgkin International Prognostic Score (CHIPS) in High‐Risk Pediatric Hodgkin Lymphoma Patients Treated on Children's Oncology Group AHOD1331

Pediatric Blood & Cancer(2025)10.1002/pbc.31856

N/A

0DataRank · unranked

1 citations

Lindsay A. Renfro, Frank G. Keller, David Hodgson, Angela Punnett, Kathleen M. McCarten +6 more

Caregiver At‐Work Productivity Loss at the Time of a Child's Diagnosis With High‐Risk Hodgkin Lymphoma: A Report From the Children's Oncology Group AHOD1331 Study

Pediatric Blood & Cancer(2025)10.1002/pbc.31841

N/A

0DataRank · unranked

1 citations

Angie Mae Rodday, Sharon M. Castellino, Lindsay A. Renfro, Debra Lerner, Tara O. Henderson +5 more

Bayesian Adaptive Enrichment Design for Continuous Biomarkers

Statistics in Medicine(2025)10.1002/sim.70262

N/A

0DataRank · unranked

1 citations

Yusha Liu, Wendy J. Mack, Lindsay A. Renfro, Yue Tu

AREN1721, a randomized phase 2 trial of axitinib+nivolumab combination therapy vs. single agent nivolumab for the treatment of TFE/translocation renal cell carcinoma (tRCC) across all age groups, an NCI National Clinical Trials Network (NCTN) phase 2 study.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.4521

N/A

0DataRank · unranked

7 citations

Lindsay A. Renfro, Matthew R. Zibelman, Ana M. Molina, Mamta Parikh, Luke Pater +8 more

Point and interval estimation in two‐stage adaptive designs with time to event data and biomarker‐driven subpopulation selection

Statistics in Medicine(2020)10.1002/sim.8557

N/A

0DataRank · unranked

15 citations

Susan Todd, Lindsay A. Renfro, Ekkehard Glimm, Josephine N. Khan, John A. Kairalla +2 more

Group-based trajectories of health-related quality of life among pediatric patients with high-risk Hodgkin lymphoma

JNCI Journal of the National Cancer Institute(2025)10.1093/jnci/djaf197

N/A

0DataRank · unranked

0 citations

Angie Mae Rodday, Lindsay A. Renfro, Yue Wu, Tara O. Henderson, Frank G. Keller +6 more

Impact of the First Generation of Children’s Oncology Group Clinical Trials on Clinical Practice for Wilms Tumor

Journal of the National Comprehensive Cancer Network(2021)10.6004/jnccn.2021.7070

N/A

0DataRank · unranked

49 citations

Elizabeth A. Mullen, David Dix, Eric J. Gratias, Peter F. Ehrlich, Najat C. Daw +9 more

Bayesian adaptive trial design for a continuous biomarker with possibly nonlinear or nonmonotone prognostic or predictive effects

Biometrics(2021)10.1111/biom.13550

N/A

0DataRank · unranked

5 citations

John A. Kairalla, Lindsay A. Renfro, Yusha Liu

Genetic changes associated with relapse in favorable histology Wilms tumor: A Children’s Oncology Group AREN03B2 study

Cell Reports Medicine(2022)10.1016/j.xcrm.2022.100644

N/A

0DataRank · unranked

33 citations

Vicki Huff, Andrew D. Skol, Lindsay A. Renfro, Conrad V. Fernandez, Elizabeth A. Mullen +8 more

Children's Oncology Group's 2023 blueprint for research: Renal tumors

Pediatric Blood & Cancer(2023)10.1002/pbc.30586

N/A

0DataRank · unranked

29 citations

Andrew L. Hong, Kelly Vallance, Nick Evageliou, Jennifer H. Aldrink, Nicholas G. Cost +4 more

Prognostic impact of lymph node involvement and loss of heterozygosity of 1p or 16q in stage III favorable histology Wilms tumor: A report from Children’s Oncology Group Studies AREN03B2 and AREN0532

Cancer(2023)10.1002/cncr.35084

N/A

0DataRank · unranked

11 citations

Lindsay A. Renfro, James I. Geller, Elizabeth J. Perlman, John A. Kalapurakal, Arnold C. Paulino +11 more

Lindsay A. Renfro

Indexed papers

Top data-sharing exemplar

Papers